Biopharmaceutical Company
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2014 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
— | $440,000 | |
| 2013 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | $280,000 | |
| 2013 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $280,000 | |
| 2013 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $280,000 | |
| 2013 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $290,000 | |
| 2013 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $450,000 | |
| 2013 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $450,000 | |
| 2012 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $270,000 | |
| 2012 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $270,000 | |
| 2012 | MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $460,000 |
| Client | Filings | Total Income |
|---|---|---|
| MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY | 33 | — |
| Name | Disclosed Prior Position |
|---|---|
| MICHAEL J EGING | N/A |
| THOMAS JOHN FUSSARO | N/A |
| AARTI SHAH |